Cubist Pharmaceuticals Completes $120 Million Financing.LEXINGTON, Mass. -- Underwriters Exercise Over-Allotment Option in Full Cubist Pharmaceuticals, Inc. (Nasdaq: CBST CBST Center for Biophotonics Science and Technology CBST Congregation Beth Simcha Torah (NYC) CBST Complete Binary Search Tree ) today announced the completion of its public offering of 9,316,700 shares of Cubist common stock at $11.20 per share. The company also announced today that the underwriters of this offering exercised in full their option to purchase an additional 1,397,500 shares of Cubist common stock at $11.20 per share. Gross proceeds of approximately $120 million represent a 20% increase over the original shelf registration statement previously filed with the Securities and Exchange Commission. Proceeds to Cubist from this offering, net of underwriting Underwriting 1. The process by which investment bankers raise investment capital from investors on behalf of corporations and governments that are issuing securities (both equity and debt). 2. The process of issuing insurance policies. discounts and commissions, and estimated offering expenses totaled $112.5 million. The sole bookrunner for the offering is Morgan Stanley  To comply with Wikipedia's , the introduction of this article needs a complete rewrite. ; Pacific Growth Equities, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control is a co-lead manager; and co-managers of the offering are WR Hambrecht+Co, Harris Nesbitt, and Wells Fargo Wells Fargo armored carriers of bullion. [Am. Hist.: Brewer Dictionary, 1147] See : Protectiveness Wells Fargo company that handled express service to western states; often robbed. [Am. Hist. Securities, LLC. This communication shall not constitute an offer to sell or the solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Cubist Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of antiinfective products that meet unmet medical needs. In the U.S., Cubist markets Cubicin(R) (daptomycin for injection), the first antibiotic in a new class of antiinfectives called lipopeptides. Cubist is headquartered in Lexington, MA. Cubist and CUBICIN are registered trademarks of Cubist Pharmaceuticals, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion